Previous 10 | Next 10 |
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that management will present at the Bank of America Global Healthcare Conferenc...
The two leading companies joined forces to develop a new Ready-To-Use vial solution, based on EZ-fill® pre-sterilized platform, allowing seamless integration into standard fill & finish lines, helping customers gaining significant increase in quality and efficiency ...
Stevanato Group S.p.A. (STVN) Q2 2022 Earnings Conference Call August 4, 2022 08:30 ET Company Participants Lisa Miles - Investor Relations Franco Stevanato - Chairman Franco Moro - Chief Executive Officer Marco Dal Lago - Chief Financial Officer Confer...
The following slide deck was published by Stevanato Group S.p.A. in conjunction with their 2022 Q2 earnings call. For further details see: Stevanato Group S.p.A. 2022 Q2 - Results - Earnings Call Presentation
Image source: The Motley Fool. Stevanato Group S.p.A. (NYSE: STVN) Q2 2022 Earnings Call Aug 04, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Stevanato Group S.p.A. (STVN) Q2 2022 Earnings Call Transcript
Stevanato Group press release ( NYSE: STVN ): Q2 Non-GAAP EPS of €0.12. Revenue of €234.2M (+14.8% Y/Y). Adjusted EBITDA totaled €61.8M with an adjusted EBITDA margin of 26.4%, For the second quarter of 2022, order intake was approximately ...
- Raises Fiscal 2022 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the secon...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the second quarter of 2022 on Thursday...
Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended June 30, 2022, Baron Health Care Fund declined 10.00% compared with the Benchmark. We are partic...
Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announces the publication of its Sustainability Report 2021. The report showcases the Group ...
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Stevanato Group S.p.A. Website:
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the second quarter of 2024 on Tuesday, August 6, 2...
2024-07-04 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...